Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy [version 2; peer review: 1 approved, 2 approved with reservations]

Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy [version 2; peer review: 1 approved, 2 approved with reservations]

Background: The 7+3 regimen is still the main choice of remission induction chemotherapy in acute myeloid leukemia (AML). Successfully achieving complete remission (CR) and the time required to achieve it determine patient’s survival. Hence, bone marrow examination on 14th day of chemotherapy is rec...

Full description

Bibliographic Details
Main Authors: Erni Juwita Nelwan, Arif Mansjoer, Hamzah Shatri, Aulia Rizka, Wulyo Rajabto, Ikhwan Rinaldi, Lyana Setiawan, Dody Ranuhardy, Dwi Wahyunianto Hadisantoso
Format: Article
Language:English
Published: F1000 Research Ltd 2022-07-01
Series:F1000Research
Subjects:
acute myeloid leukemia
leukocyte nadir
induction chemotherapy
complete remission
association
eng
Online Access:https://f1000research.com/articles/11-495/v2

Internet

https://f1000research.com/articles/11-495/v2

Similar Items